Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

7.6%

17 terminated/withdrawn out of 225 trials

Success Rate

87.0%

+0.5% vs industry average

Late-Stage Pipeline

14%

31 trials in Phase 3/4

Results Transparency

3%

3 of 114 completed trials have results

Key Signals

38 recruiting3 with results13 terminated4 withdrawn

Enrollment Performance

Analytics

N/A
97(62.6%)
Phase 2
20(12.9%)
Phase 4
16(10.3%)
Phase 3
15(9.7%)
Phase 1
7(4.5%)
155Total
N/A(97)
Phase 2(20)
Phase 4(16)
Phase 3(15)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (225)

Showing 20 of 225 trials
NCT04444492Phase 3Active Not Recruiting

Combination of Ranibizumab and Targeted Laser Photocoagulation

Role: collaborator

NCT02083835Recruiting

PAIN OUT: Improvement in Postoperative PAIN OUTcome

Role: collaborator

NCT06112171Not ApplicableRecruiting

Comparison of a Lithotripsy vs Standard Preparation Followed by Stenting With Supera Stent in Femoropopliteal Lesions

Role: lead

NCT06656832Not ApplicableRecruiting

Peripheral Drivers of Heart Failure Progression - The Prospective PEDAL-HF Study

Role: lead

NCT03776799Not ApplicableActive Not Recruiting

BEST SFA Pilot Study - Best Endovascular STrategy for Complex Lesions of the Superficial Femoral Artery

Role: lead

NCT06269263Not ApplicableCompleted

Feasibility of Home-based Cardiac Rehabilitation in Patients With Chronic Heart Failure (Pilot-CRHF)

Role: lead

NCT06056505Not ApplicableCompleted

Virtual Interactive 3D Modelling to Improve Outcomes in Robotic-Assisted Partial Nephrectomy

Role: lead

NCT06931938Not ApplicableRecruiting

Awake Prone Positioning in Spontaneous Breathing Patients With Acute Hypoxic Respiratory Failure Due to Pneumonia

Role: collaborator

NCT05833438Phase 2Active Not Recruiting

Venetoclax in Combination With 5 Days Azacitidine in Untreated AML Patients, Not Eligible for Standard Induction Therapy

Role: lead

NCT06576934Not ApplicableRecruiting

Early TIPS in Patients With Liver Cirrhosis and Ascites

Role: collaborator

NCT03469609Not ApplicableRecruiting

Mucous Fistula Refeeding Reduces the Time From Enterostomy Closure to Full Enteral Feeds ("MUC-FIRE" Trial)

Role: lead

NCT07155564Recruiting

Validation of Energy Expenditure Measures Study

Role: lead

NCT06832579Not ApplicableActive Not Recruiting

SmartWatch-driven AF Detection in Stroke Patients

Role: lead

NCT07549607Not Yet Recruiting

Clinical Characterization of Patients With Primary Biliary Cirrhosis Treated With Seladelpar in the Real-life Setting

Role: lead

NCT04607096Not ApplicableRecruiting

Intermittent Fasting to Improve Insulin Secretion

Role: collaborator

NCT05582902Active Not Recruiting

Study Investigating Patient-Reported Outcomes in Lower-risk MDS Patients

Role: lead

NCT04862273Completed

CMR T1 Mapping for Diagnosis of Cardiac Amyloidosis

Role: lead

NCT04498780Completed

Hemodynamic Effects of ARNI on Noninvasive Pressure-volume Analysis in Patients With Chronic Heart Failure

Role: lead

NCT06656988Phase 3Recruiting

A Contrast Medium Sparing Strategy Using Automated CO2 Injection During PVI for Prevention of Major Adverse Kidney Events (MAKE)

Role: lead

NCT07462624Not ApplicableRecruiting

REpeat Intervention For Failed Surgical BioProsthEtic AorTic Valves (REPEAT)

Role: collaborator